NIP
GNMK

Nicholas Investment Partners’s GenMark Diagnostics, Inc GNMK Stock Holding History

Nicholas Investment Partners’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-126,899
Closed -$1.69M – 336
2013
Q4 		$1.69M Buy
+126,899
New +$1.54M 0.13% 247

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Nicholas Investment Partners's GNMK Position: Q1 2014 in Review

Nicholas Investment Partners sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2014, closing a stake of 126,899 shares — an estimated $1.69M sold.

Nicholas Investment Partners first reported a position in GNMK in Q4 2013 and held it in 1 quarter. The position peaked at $1.69M in Q4 2013. 78 funds tracked by Wall St. Rank hold GNMK as of Q1 2014.

  • Nicholas Investment Partners reported no remaining GenMark Diagnostics, Inc position as of Q1 2014 after selling out during the quarter.
  • Nicholas Investment Partners sold 126,899 GenMark Diagnostics, Inc shares in Q1 2014, an estimated $1.69M.
  • Nicholas Investment Partners first reported a position in GenMark Diagnostics, Inc in Q4 2013 and held it in 1 quarter.
  • Nicholas Investment Partners's GenMark Diagnostics, Inc position peaked at $1.69M in Q4 2013.
  • 78 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2014.

Based on Nicholas Investment Partners's 13F filing for Q1 2014, filed 8 May 2014.